Answer
Nausea was reported in 35% of patients taking Korserdu (elacestrant dihydrochloride), with Grade 3–4 nausea reported in 2.5%.
Sources for this answer
- Korserdu (elacestrant) 345mg film-coated tabletsMenarini Stemline UK Ltd · emc · SmPC §4.8 Undesirable effects · Version 3Document updated
Sources checked